NewsRx

Search our medical news database

Business & Finance

510k filed with FDA for ultrasound biomicroscope, company financials reported

Published in Medical Letter on the CDC and FDA, May 29th, 2005

Paradigm Medical Industries, Inc., (PMED.OB/PMEDW.OB) announced that it has filed a 510(k) with the U.S. Food and Drug Administration (FDA) for its new generation ultrasound biomicroscope (UBM).

The company was recently awarded the CE Mark for the P60 UBM, which will enable it to market the device in 19 Western European countries and some parts of the Pacific Rim.

A 510(k) is a formal marketing application to the FDA to gain clearance for specific indications of use for a device. With FDA approval, the new device will be available for sale in the United States.

"The P60 represents the latest generation of our UBM devices," said...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook